MSK House, London Road, Silk Willoughby, Sleaford NG34 8NY
Blogs
Browse every article from Lincolnshire Knee.
ChondroFiller bridges the treatment gap between failed conservative care and knee replacement for patients with focal cartilage damage. This injectable collagen scaffold provides a structural matrix that recruits the patient's own cells, with treated patients showing mean functional improvements ...
At ten years, osteochondral autograft shows 14% treatment failure versus 38% for microfracture in athletes with focal knee cartilage defects. The gap, invisible at two years, widens decisively from year five onwards.
The distribution of arthritis across the knee's three compartments — not pain severity or preference — determines whether partial or total knee replacement is appropriate. Partial replacement addresses single-compartment disease; total replacement addresses multi-compartmental disease.
ACL grafts reach only 50% strength at six months due to ligamentisation—controlled cell death followed by fibroblast conversion into functional ligament over two years—which is why contact sport return is delayed until nine months.
Knee cartilage repair choice hinges on lesion size: defects under 2 cm² take a single OATS plug creating a seamless hyaline cartilage layer, whilst lesions of 2–4 cm² require mosaicplasty's multiple smaller plugs, which inevitably leave gaps filled with inferior fibrocartilage.
Hyaluronic acid restores lubrication in osteoarthritic joints. ChondroFiller is a collagen scaffold that recruits progenitor cells to regenerate focal cartilage defects.
World-class orthopaedic surgeon
Consultant Cartilage Surgeon • Visiting Professor, University of Lincoln
Biology-led, faster return to activity.
Advanced OA injection for relief.
Keyhole cartilage regeneration.
“Regenerative science plus precise surgery and rehab can shorten recovery and protect long-term joint health.”
Ready to move again?
Self-referrals welcome. Insured and self-pay accepted.
